What is Quince Therapeutics, Inc.?
, a biotechnology company, focuses on acquiring, developing, and commercializing therapeutics for patients with debilitating and rare diseases.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
, a biotechnology company, focuses on acquiring, developing, and commercializing therapeutics for patients with debilitating and rare diseases. The company's lead asset candidature comprises eDSP, which is in Phase 3, for the treatment of rare pediatric neurodegenerative disease, including A-T, an inherited autosomal recessive neurodegenerative and immunodeficiency disorder caused by mutations in ATM gene. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 32.27M.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.